BARD1 and non-small cell lung carcinoma: In CRC and NSCLC, the expression of BARD1-FL was associated with increased survival [14,18,101], while the SNP rs7585356, which overexpressed BARD1-FL, was associated with decreased susceptibility to high-risk NB [86,89].